Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	May 30, 2026	May 31, 2025	Jun. 01, 2024
Operating activities:
Net income (loss)	$ 6,383	$ (1,143)	$ 61
Adjustments to reconcile net income to cash provided by operating activities:
Unrealized foreign currency gain	(24)	(1,002)	(304)
Depreciation and amortization	3,789	4,002	4,307
Inventory provisions	499	550	606
Share-based compensation expense	1,621	1,545	1,326
Loss on disposal of property, plant and equipment	10	16	70
Deferred income taxes	1,060	(3,257)	(1,004)
(Gain) loss on disposal of healthcare assets and related charges	(847)	5,074	0
Change in assets and liabilities:
Accounts receivable	(8,909)	130	5,297
Inventories	742	206	66
Prepaid expenses and other assets	(2,265)	(180)	250
Accounts payable	(1,870)	5,525	(8,124)
Accrued liabilities	1,127	(1,240)	3,396
Other	(554)	326	577
Net cash provided by operating activities	762	10,552	6,524
Investing activities:
Capital expenditures	(4,383)	(2,811)	(4,041)
Proceeds from the sale of property, plant and equipment	0	7	0
Proceeds from disposal of healthcare assets	1,300	6,827	0
Net cash (used in) provided by investing activities	(3,083)	4,023	(4,041)
Financing activities:
Proceeds from issuance of common stock	993	320	591
Cash dividends paid on common and Class B common stock	(3,439)	(3,407)	(3,376)
Proceeds from revolving credit facility	0	1,000	3,744
Repayment of revolving credit facility	0	(1,000)	(3,744)
Other	(98)	(159)	(120)
Net cash used in financing activities	(2,544)	(3,246)	(2,905)
Effect of exchange rate changes on cash and cash equivalents	743	309	(296)
(Decrease) increase in cash and cash equivalents	(4,122)	11,638	(718)
Cash and cash equivalents at beginning of period	35,901	24,263	24,981
Cash and cash equivalents at end of period	31,779	35,901	24,263
Cash paid during the fiscal year:
Income taxes, net of refunds	1,738	1,821	0
Non-cash activities:
Accruals for construction in progress	312	0	267
Right of use assets obtained in exchange for lease liabilities	$ 303	$ 730	$ 1,518